KRISTEN STARZYNSKI: Open Payments
NPI 1376068809 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$602 in 26 payments from 8 companies in 2025. Trend: 2023 $585 · 2024 $810 · 2025 $602
Food & beverage: $504Education: $98
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $222 |
| Alkermes, Inc. | 6 | $110 |
| ABBVIE INC. | 4 | $68 |
| Janssen Pharmaceuticals, Inc | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $17 |
Products named: ARISTADA, UZEDY, VRAYLAR, COBENFY, FANAPT, REXULTI, INVEGA SUSTENNA, SPRAVATO.
Industry payments across TX — which companies pay providers there.
